Mark Hancock, a director and ten percent owner of PACS Group, Inc. (NASDAQ:PACS), recently executed a series of stock transactions totaling approximately $1.14 million. The sales were conducted over two consecutive days in July 2026 under a pre-existing Rule 10b5-1 trading plan. This activity takes place as PACS Group trades near its 52-week high of $45.89, following a substantial 238% return over the past year.
The initial transaction occurred on July 8, 2026, when Hancock disposed of 20,338 shares of common stock. These shares were sold at a weighted average price of $45.0689, with individual sale prices ranging from $45.00 to $45.2861 per share. The following day, July 9, 2026, an additional 4,966 shares were sold at a weighted average price of $45.0627. The prices for these transactions ranged from $45.00 to $45.255 per share.
Both sales were conducted directly and were part of a Rule 10b5-1 trading plan that Hancock adopted on March 11, 2026. Following these transactions, Mark Hancock directly holds 53,920,512 shares of PACS Group, Inc. common stock. According to InvestingPro analysis, PACS appears overvalued at current levels, with 12 additional ProTips available to subscribers.
In other recent news, PACS Group Inc. reported impressive financial results for the first quarter of 2026, exceeding earnings expectations with an earnings per share (EPS) of $0.50 compared to the anticipated $0.44. This represents a 13.64% surprise, while revenue increased by 11% year-over-year to reach $1.42 billion. Additionally, PACS Group announced a significant expansion through a definitive agreement to acquire 34 skilled nursing facilities from Eduro Healthcare. These facilities, which add 3,633 skilled nursing beds, are spread across six western states, including Texas and Montana.
In a related development, Truist Securities reiterated its Buy rating on PACS Group stock, setting a price target of $52.00. The firm cited strong demand trends and the company’s clinical and operational execution as key factors in their analysis. Furthermore, options trading activity in PACS Group saw a notable increase, with a total of 7,248 contracts traded. Call options dominated the activity, accounting for 7,245 contracts. These developments reflect the company’s strategic growth and financial performance in recent times.